-
1Academic Journal
المؤلفون: Cornu, Marjorie, Bruno, Benedicte, Loridant, Severine, Navarin, Pauline, Francois, Nadine, Lanternier, Fanny, Amzallag-Bellenger, Elisa, Dubos, Francois, Mazingue, Francoise, Sendid, Boualem
المساهمون: Lille Inflammation Research International Center - U 995 (LIRIC), Institut Pasteur de Lille, Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Mycologie moléculaire - Molecular Mycology, Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS), Centre National de Référence Mycoses Invasives et Antifongiques - National Reference Center Invasive Mycoses & Antifungals (CNRMA), Institut Pasteur Paris (IP), Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), This work was supported by internal funding “Fonds d’aide à l’émergence et à l’excellence du CHRU de Lille-Bonus H”.
المصدر: ISSN: 2050-6511 ; BMC Pharmacology and Toxicology ; https://hal.univ-lille.fr/hal-02513581 ; BMC Pharmacology and Toxicology, 2018, 19, pp.81. ⟨10.1186/s40360-018-0273-7⟩.
مصطلحات موضوعية: Lichtheimia, Drug-monitoring, Mucormycosis, Paediatrics, Isavuconazole, MESH: Acute Disease, MESH: Amphotericin B/therapeutic use, MESH: Pyridines/therapeutic use, MESH: Treatment Outcome, MESH: Triazoles/therapeutic use, MESH: Antifungal Agents/therapeutic use, MESH: Child, Preschool, MESH: Drug Therapy, Combination, MESH: Female, MESH: Humans, MESH: Leukemia, B-Cell/drug therapy, MESH: Mucormycosis/drug therapy, MESH: Nitriles/therapeutic use, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics
Relation: info:eu-repo/semantics/altIdentifier/pmid/30522521; PUBMED: 30522521; PUBMEDCENTRAL: PMC6282241
-
2
المؤلفون: Cornu, M. (Marjorie), Bruno, B. (Benedicte), Loridant, S. (Severine), Navarin, P. (Pauline), Francois, N. (Nadine), Lanternier, F. (Fanny), Amzallag-Bellenger, E. (Elisa), Dubos, F. (Francois), Mazingue, F. (Francoise), Sendid, B. (Boualem)
المساهمون: Lille Inflammation Research International Center - U 995 (LIRIC), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Mycologie moléculaire - Molecular Mycology, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Centre National de Référence Mycoses Invasives et Antifongiques - National Reference Center Invasive Mycoses & Antifungals (CNRMA), Institut Pasteur [Paris], Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), This work was supported by internal funding 'Fonds d’aide à l’émergence et à l’excellence du CHRU de Lille-Bonus H'., Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP), Lille Inflammation Research International Center (LIRIC), Centre d'infectiologie Necker-Pasteur [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Santé publique : épidémiologie et qualité des soins-EA 2694 (CERIM), Université de Lille, LillOA, CHU Lille, Inserm, Université de Lille, Lille Inflammation Research International Center - U 995 [LIRIC], Lille Inflammation Research International Center (LIRIC) - U995, Centre Hospitalier Régional Universitaire [Lille] [CHRU Lille], METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
المصدر: BMC Pharmacology and Toxicology
BMC Pharmacology and Toxicology, BioMed Central, 2018, 19, pp.81. ⟨10.1186/s40360-018-0273-7⟩
BMC Pharmacology and Toxicology, 2018, 19, pp.81. ⟨10.1186/s40360-018-0273-7⟩
BMC Pharmacology & Toxicology
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-5 (2018)مصطلحات موضوعية: MESH: Leukemia, B-Cell/drug therapy, Antifungal Agents, Pyridines, Case Report, Isavuconazole, Mucormycosis, Paediatrics, Drug-monitoring, Lichtheimia, MESH: Mucormycosis/drug therapy, [SDV.MHEP.PED] Life Sciences [q-bio]/Human health and pathology/Pediatrics, lcsh:RA1190-1270, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Amphotericin B, Nitriles, Leukemia, B-Cell, MESH: Pyridines/therapeutic use, Humans, MESH: Nitriles/therapeutic use, lcsh:Toxicology. Poisons, MESH: Treatment Outcome, [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics, MESH: Humans, lcsh:RM1-950, MESH: Child, Preschool, Triazoles, MESH: Amphotericin B/therapeutic use, MESH: Drug Therapy, Combination, lcsh:Therapeutics. Pharmacology, Treatment Outcome, MESH: Antifungal Agents/therapeutic use, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Child, Preschool, Acute Disease, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Triazoles/therapeutic use, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, MESH: Acute Disease, Drug Therapy, Combination, Female, MESH: Female
وصف الملف: application/pdf; application/octet-stream; application/rdf+xml; charset=utf-8
-
3
المؤلفون: Sipho Dlamini, Martin Dedicoat, Navin Paul, Derek J. Sloan
المصدر: The Cochrane Library
The Cochrane Database of Systematic Reviewsمصطلحات موضوعية: Antifungal Agents, mesh:Drug Administration Schedule, mesh:HIV Infections, mesh:Health Resources, Flucytosine, HIV Infections, mesh:Developing Countries, Meningitis, Cryptococcal, mesh:Acetazolamide/adverse effects, mesh:Flucytosine/supply & distribution, mesh:Meningitis, Cryptococcal, mesh:Flucytosine/therapeutic use, mesh:HIV Infections/complications, mesh:Acute Disease, Pharmacology (medical), mesh:Intracranial Hypertension, Fluconazole, First episode, mesh:Amphotericin B/supply & distribution, biology, mesh:Induction Chemotherapy/methods, mesh:Intracranial Hypertension/drug therapy, mesh:Antifungal Agents/supply & distribution, mesh:Meningitis, Cryptococcal/mortality, mesh:Acetazolamide, Acute Disease, Health Resources, mesh:Humans, mesh:Adult, mesh:Fluconazole/supply & distribution, Meningitis, mesh:Antifungal Agents/therapeutic use, medicine.drug, Adult, Medicine General & Introductory Medical Sciences, medicine.medical_specialty, mesh:Drug Therapy, Combination, mesh:Induction Chemotherapy, mesh:Fluconazole, mesh:Antifungal Agents, Amphotericin B, Internal medicine, medicine, Humans, mesh:Network Meta‐Analysis, Dosing, Intensive care medicine, Adverse effect, Developing Countries, mesh:Flucytosine, Antihypertensive Agents, Cryptococcus neoformans, mesh:Meningitis, Cryptococcal/drug therapy, mesh:Health Resources/supply & distribution, business.industry, mesh:Amphotericin B/therapeutic use, biology.organism_classification, medicine.disease, mesh:Fluconazole/therapeutic use, Acetazolamide, Regimen, Intracranial Hypertension, business, mesh:Amphotericin B